Biometrics Built Better

Dealing with Reality: Using Regulatory and Biostatistics Strategies to Adapt to the Unexpected in Clinical Trials

Share this article

Join Veramed’s Debra Anderson, SVP, Strategic Partnerships, Mark Holland, Head of Programming Delivery, and Facet Life Science’s Lisa Jenkins VanLuvanee, COO & VP, R&D and Jason Mercer, Regulatory Affairs Consultant, to discover actionable insights to help you respond to unexpected challenges in clinical trials with confidence.

Agenda Highlights:

  • Managing unexpected clinical trial disruptions
  • Decision-making for rescue scenarios
  • Case studies on overcoming regulatory and biometric challenges

Share this article

Stay Connected

Sign up to receive the latest insights, case studies, and Veramed news—straight to your inbox.

Related Posts